Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Neuroscience

Jazz Pharmaceuticals Accesses First Approved Cannabidiol-based Medicine & Pipeline with $7.2b Acquisition of GW Pharmaceuticals Plc

Ireland-domiciled Jazz Pharmaceutical is apparently sold as the first developer of what is the first and only U.S. Food and […]

Jazz Pharmaceuticals Accesses First Approved Cannabidiol-based Medicine & Pipeline with $7.2b Acquisition of GW Pharmaceuticals Plc
1 month ago
Share

Vanderbilt University Secures $20m from William K. Warren Foundation to Further Treatments for Brain Disorders

Vanderbilt University received $20 million from the William K Warren Foundation located in Tulsa, Oklahoma to establish the Warren Center […]

Vanderbilt University Secures $20m from William K. Warren Foundation to Further Treatments for Brain Disorders
10 months ago
Share

UCSF Memory & Aging Center Conduct Basket Trials to Explore Acceleration of Neurodegenerative Disease Drug Development

The UC San Francisco Memory and Aging Center (MAC) has developed a new type of clinical trial for dementia aiming to […]

UCSF Memory & Aging Center Conduct Basket Trials to Explore Acceleration of Neurodegenerative Disease Drug Development
1 year ago
Share

NIH BRAIN Initiative Collaboration Reviews Clinical Research Considerations and Obligations

The National Institutes of Health’s Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative represents the next generation of powerful new […]

NIH BRAIN Initiative Collaboration Reviews Clinical Research Considerations and Obligations
1 year ago
Share

Clinical Trials and Research News Weekly Roundup | 9-16-2019 S1 E10

Join us as we go over our top stories from the week: Advanced Gene Therapy TR002 Moves to Phase III […]

youtube roundup
1 year ago
Share

Mount Sinai Launches the Lipschultz Center for Cognitive Neuroscience

A new Mount Sinai research center will focus on understanding the neural mechanisms of higher cognitive function, and applying this […]

Mount Sinai Launches the Lipschultz Center for Cognitive Neuroscience
2 years ago
Share

Rush University Medical Centers Building $450m State-of-Art Cancer and Neuroscience Center to Include Expanded Clinical Trials

Rush University Medical Center has commenced construction on its new $450 million Cancer and Neurosciences Center in Chicago. The groundbreaking […]

Cancer Centr
2 years ago
Share

Neurocrine Biosciences Presents Positive Data From BIPARK-1 and -2 Studies of Opicapone for Parkinson’s Disease

Neurocrine Biosciences announced data analysis from two phase 3 trials evaluating opicapone added to levodopa for Parkinson’s disease was presented […]

Parkinson Disease
2 years ago
Share

Yale New Haven Plans $838M Neuroscience Center

Yale plans a state-of-the-art, $838 million neuroscience center with a focus on treatment for diseases such as Parkinson’s, Alzheimer’s and […]

2 years ago
Share

Washington University Investing $300 Million in New Neuroscience Building

Washington University St. Louis confirmed the development of a planned $300 million neuroscience building project. It is in the early […]

2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.